Anticancer Drugs Course
Gain expertise in managing EGFR-mutated NSCLC with this Anticancer Drugs Mastery Course. Learn to select optimal first-line EGFR TKI therapies, handle common toxicities like rash and diarrhea, address resistance through biopsies and second-line plans, and counsel patients clearly. Ideal for oncology professionals seeking evidence-based tools to improve patient outcomes and streamline care in busy clinical settings.

flexible workload of 4 to 360h
valid certificate in your country
What will I learn?
This course provides a practical guide to first-line treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy options. Participants will explore drug mechanisms, dosing schedules, toxicity management, resistance mechanisms, follow-up treatments, monitoring protocols, and effective patient communication skills for better clinical decisions.
Elevify advantages
Develop skills
- Select EGFR TKIs for first-line treatment based on latest trial data.
- Plan resistance assessments using imaging, tissue biopsy, and liquid biopsy.
- Develop second-line plans matching resistance to targeted or chemo options.
- Prevent and treat toxicities such as EGFR TKI rash, diarrhoea, ILD, and low blood counts.
- Counsel patients on treatment aims, side effects, and next steps in simple terms.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workloadWhat our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course